Generate:Biomedicines is a biotechnology company pioneering AI-driven protein therapeutics. Using generative artificial intelligence, it designs and develops novel protein-based drugs for immunology, oncology, and infectious diseases. Founded by Flagship Pioneering, the company has raised $700 million since 2020 to advance its therapeutic pipeline. Its first program is now in clinical trials, with plans to initiate multiple new studies each year.